TALARICO, ROSARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.340
AS - Asia 1.810
EU - Europa 1.200
SA - Sud America 322
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 119
OC - Oceania 8
Totale 6.928
Nazione #
US - Stati Uniti d'America 3.222
SG - Singapore 576
CN - Cina 479
SE - Svezia 357
HK - Hong Kong 274
BR - Brasile 267
VN - Vietnam 257
IT - Italia 248
DE - Germania 148
BG - Bulgaria 93
CA - Canada 82
GB - Regno Unito 78
FI - Finlandia 68
FR - Francia 64
RU - Federazione Russa 46
IN - India 45
CI - Costa d'Avorio 41
TR - Turchia 39
SN - Senegal 31
AR - Argentina 24
JP - Giappone 22
MX - Messico 19
PK - Pakistan 17
UA - Ucraina 17
IQ - Iraq 16
PL - Polonia 16
BD - Bangladesh 15
ID - Indonesia 14
NL - Olanda 14
NG - Nigeria 13
MA - Marocco 12
EC - Ecuador 10
AT - Austria 9
SA - Arabia Saudita 9
AU - Australia 8
LT - Lituania 8
ZA - Sudafrica 8
ES - Italia 7
UZ - Uzbekistan 7
BE - Belgio 6
KE - Kenya 6
CR - Costa Rica 5
EG - Egitto 5
MY - Malesia 5
PE - Perù 5
TN - Tunisia 5
AL - Albania 4
CL - Cile 4
CO - Colombia 4
LB - Libano 4
PH - Filippine 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
JO - Giordania 3
KR - Corea 3
OM - Oman 3
PY - Paraguay 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
IL - Israele 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
LY - Libia 2
PA - Panama 2
PT - Portogallo 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
MV - Maldive 1
NI - Nicaragua 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SO - Somalia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.810
Città #
Ashburn 393
Dallas 301
Singapore 296
Hong Kong 271
Woodbridge 228
Santa Clara 216
Fairfield 210
San Jose 190
Houston 175
Chandler 146
Ann Arbor 132
Beijing 129
Shanghai 120
Seattle 98
Sofia 92
Wilmington 84
Cambridge 83
New York 81
Ho Chi Minh City 73
Los Angeles 73
Munich 59
Hanoi 57
Boardman 51
Ottawa 43
Abidjan 41
Princeton 39
Lawrence 38
Florence 35
Frankfurt am Main 35
Dakar 31
Lauterbourg 31
Medford 31
London 30
Turku 30
Bremen 25
Council Bluffs 25
São Paulo 24
Jacksonville 23
Des Moines 22
Helsinki 21
Milan 19
Serra 19
Buffalo 18
Pisa 18
Redondo Beach 18
Istanbul 17
Rome 17
Nanjing 16
Tokyo 16
Izmir 15
Montreal 15
San Diego 15
Ogden 14
Dong Ket 12
Belo Horizonte 11
Lagos 11
Rio de Janeiro 11
Lancaster 10
Orem 10
Phoenix 10
Dearborn 9
Kunming 9
Manchester 9
Mumbai 9
Poplar 9
Pune 9
Shenyang 9
Warsaw 9
Atlanta 8
Boulder 8
Brooklyn 8
Casablanca 8
Chennai 8
Chicago 8
Haiphong 8
Montecatini Terme 8
Toronto 8
Hải Dương 7
Nanchang 7
San Francisco 7
Vienna 7
Bologna 6
Boston 6
Brussels 6
Düsseldorf 6
Fuzhou 6
Hebei 6
Lahore 6
Mexico City 6
Nairobi 6
Tashkent 6
Baghdad 5
Baltimore 5
Bari 5
Campinas 5
Columbus 5
Da Nang 5
Denver 5
Hangzhou 5
Hefei 5
Totale 4.651
Nome #
Skin manifestations and sjögren’s syndrome 236
Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study 205
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 203
Classification criteria 197
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 185
Skin manifestations and cryoglobulinemia 180
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 179
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 170
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 168
Classification criteria for Sjogren's syndrome: A critical review. 164
A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease 157
Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center 155
Undifferentiated connective tissue diseases (UCTD): Simplified systemic autoimmune diseases 154
COVID-19: the new challenge for rheumatologists 152
Sjögren's syndrome: state of the art on clinical practice guidelines 146
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 145
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases 144
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 142
Cryoglobulinemic vasculitis: a 2023 update 142
Systemic lupus erythematosus: state of the art on clinical practice guidelines 141
COVID-19: the new challenge for rheumatologists. First update 138
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 136
One year in review 2020: vasculitis 130
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus 126
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison 125
Anticoagulation in venous thromboembolism in Behçet’s syndrome: friend or foe? 120
Systemic vasculitis: an annual critical digest of the most recent literature 120
Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? 112
null 107
Long-Term Outcome of Idiopathic Uveitis: A Prospective Cohort Study 107
One year in review 2021: systemic vasculitis 106
One year in review 2017: novelties in the treatment of rheumatoid arthritis 105
One year in review 2017: systemic vasculitis 103
One year in review 2018: systemic vasculitis 101
Behçet's syndrome and ocular involvement: changes over time 100
Systemic vasculitis: one year in review 2024 94
null 94
Development of de novo major involvement duringfollow-up in Behçet's syndrome 94
Analysis of the evolution of UCTD to defined CTD after a long term follow-up 90
null 89
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway. 87
Successful treatment of refractory adult-onset still disease with canakinumab: a case report. 87
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome 87
Systemic vasculitis: one year in review 2023 86
Mortality in giant cell arteritis: analysis of a monocentric cohort of biopsy-proven patients 84
Systemic vasculitis and the lung 81
The role of tobacco smoking in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review 77
Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis? 75
Sleep and circadian parameters in Behçet’s syndrome: a comparative analysis using actigraphy and questionnaires 72
Patient Care Pathways for Pregnancy in Rare and Complex Rheumatic Diseases: Results From an International Survey. 71
Systemic vasculitis: one year in review 2022 67
Funzioni del connettivo 64
null 62
Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks (Orphanet Journal of Rare Diseases, (2020), 15, 1, (347), 10.1186/s13023-020-01631-1) 53
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 49
FRI0607 IDENTIFICATION OF UNMET NEEDS RELATED TO RARE AND COMPLEX CONNECTIVE TISSUE AND MUSCULOSKELETAL DISEASES (RCTDS) ACROSS EU: THE EXPERIENCE OF THE ERN RECONNET 49
Systemic vasculitis: one year in review 2025 46
Challenges in the transition of care for rare connective tissue diseases: results from the 2023 ERN ReCONNET Transition of Care Task Force survey 38
null 30
FRI0036Meta-Immunological Profiling of Patients with Behçet's Disease Reveals Novel Biomarkers of Disease Activity, Progression and Response To Therapy 24
null 24
null 22
null 20
Exploring sleep health and circadian rhythm disruption in Sjögren's disease: an accelerometric and self-reported cross-sectional study 11
Totale 6.928
Categoria #
all - tutte 20.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022392 0 15 0 37 80 51 3 21 17 12 42 114
2022/2023683 106 126 52 44 56 68 11 43 112 7 50 8
2023/2024368 14 20 43 22 56 88 40 9 11 2 19 44
2024/20251.495 5 41 40 66 141 184 116 73 131 186 220 292
2025/20262.302 135 275 320 283 259 173 334 115 100 207 54 47
2026/2027126 109 17 0 0 0 0 0 0 0 0 0 0
Totale 6.928